StageZero Life Sciences Ltd
TSX:SZLS

Watchlist Manager
StageZero Life Sciences Ltd Logo
StageZero Life Sciences Ltd
TSX:SZLS
Watchlist
Price: 0.04 CAD Market Closed
Market Cap: 4.9m CAD

Wall Street
Price Targets

SZLS Price Targets Summary
StageZero Life Sciences Ltd

There are no price targets for SZLS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
StageZero Life Sciences Ltd Competitors:
Price Targets
XGN
Exagen Inc
145% Upside
6628
Transcenta Holding Limited
568% Upside
ENTA
Enanta Pharmaceuticals Inc
26% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
30% Upside
COV
Covalon Technologies Ltd
124% Upside
APLS
Apellis Pharmaceuticals Inc
47% Upside
6160
Beigene Ltd
42% Upside
XNCR
Xencor Inc
84% Upside

Revenue
Forecast

Revenue Estimate
StageZero Life Sciences Ltd

For the last 11 years the compound annual growth rate for StageZero Life Sciences Ltd's revenue is 39%. The projected CAGR for the next 2 years is 22%.

39%
Past Growth
22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
StageZero Life Sciences Ltd

Operating Income forecast
is not available for
StageZero Life Sciences Ltd

Net Income
Forecast

Net Income Estimate
StageZero Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SZLS's stock price target?
Not Available

SZLS doesn't have any price targets made by Wall Street professionals.

What is StageZero Life Sciences Ltd's Revenue forecast?
Projected CAGR
22%

For the last 11 years the compound annual growth rate for StageZero Life Sciences Ltd's revenue is 39%. The projected CAGR for the next 2 years is 22%.

Back to Top